The pathogenic role of the renal proximal tubular cell in diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3049-3056

  Tang, Sydney C W ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

db db mice; diabetic nephropathy; fibrosis; inflammation; kallikrein kinin system; proximal tubular epithelial cell; TLR4 KO mice; toll like receptor

Indexed keywords

GLUCOSE; KALLIKREIN; KININ; MESSENGER RNA; TOLL LIKE RECEPTOR;

ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; EXTRACELLULAR MATRIX; GLUCOSE TRANSPORT; HUMAN; INNATE IMMUNITY; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE CELL; KIDNEY TUBULE CELL; MACROALBUMINURIA; MICROALBUMINURIA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PROTEINURIA; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DIABETIC NEPHROPATHIES; FIBROSIS; GLUCOSE; HUMANS; INFLAMMATION; KALLIKREIN-KININ SYSTEM; KIDNEY TUBULES, PROXIMAL; MICE; MODELS, ANATOMIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84864601012     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs260     Document Type: Article

References (85)

1. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2011; 8: 228-236.
2. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
3. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
4. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 353-365.
5. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135: 719-733.
6. Wang Y, Chen J, Chen L et al. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8: 1537-1545.
7. Zoja C, Donadelli R, Colleoni S et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NFkappa B activation. Kidney Int 1998; 53: 1608-1615.
8. Tang S, Sheerin NS, Zhou W et al. Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol 1999; 10: 69-76.
9. Tang S, Leung JC, Tsang AW et al. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria. Kidney Int 2002; 61: 1655-1665.
10. Tang S, Leung JC, Abe K et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003; 111: 515-527.
11. Lai KN, Leung JC, Chan LY et al. Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state. Kidney Int 2007; 71: 526-538.
12. Tang S, Lai KN, Chan TM et al. Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis 2001; 37: 94-103.
13. Takaya K, Koya D, Isono M et al. Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol Renal Physiol 2003; 284: F1037-F1045.
14. Donadelli R, Zanchi C, Morigi M et al. Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways. J Am Soc Nephrol 2003; 14: 2436-2446.
15. Nakajima H, Takenaka M, Kaimori JY et al. Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol 2004; 15: 276-285.
16. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217.
17. Diwakar R, Pearson AL, Colville-Nash P et al. The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells. Am J Physiol Renal Physiol 2007; 292: F1464-F1470.
18. Stephan JP, Mao W, Filvaroff E et al. Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells. Am J Nephrol 2004; 24: 14-19.
19. Duffield JS, Humphreys BD. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011; 79: 494-501.
20. Fragiadaki M, Mason RM. Epithelial-mesenchymal transition in renal fibrosis-evidence for and against. Int J Exp Pathol 2011; 92: 143-150.
21. Kriz W, Kaissling B, Le HM. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
22. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010; 21: 1247-1253.
23. Ruggenenti P, Perna A, Mosconi L et al. Urinary protein excretion rate is the best independent predictor of ESRF in nondiabetic proteinuric chronic nephropathies. 'Gruppo Italiano di Studi Epidemiologici in Nefrologia' (GISEN). Kidney Int 1998; 53: 1209-1216.
24. de Zeeuw D, Remuzzi G, Parving HH et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309-2320.
25. Tang SC, Tang AW, Wong SS et al. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int 2010; 77: 543-549.
26. Russo LM, Sandoval RM, McKee M et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 2007; 71: 504-513.
27. Christensen EI, Birn H, Rippe B et al. Controversies in nephrology: renal albumin handling, facts, and artifacts! Kidney Int 2007; 72: 1192-1194.
28. Tanner GA. Glomerular sieving coefficient of serum albumin in the rat: a two-photon microscopy study. Am J Physiol Renal Physiol 2009; 296: F1258-F1265.
29. Comper WD, Russo LM. Where does albuminuria come from in diabetic kidney disease? Curr Diab Rep 2008; 8: 477-485.
30. Ziyadeh FN, Snipes ER, Watanabe M et al. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990; 259: F704-F714.
31. Ziyadeh FN, Simmons DA, Snipes ER et al. Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose. J Am Soc Nephrol 1991; 1: 1220-1229.
32. Rocco MV, Chen Y, Goldfarb S et al. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int 1992; 41: 107-114.
33. Han DC, Hoffman BB, Hong SW et al. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol 2000; 278: F628-F634.
34. Chen S, Hoffman BB, Lee JS et al. Cultured tubule cells from TGFbeta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Kidney Int 2004; 65: 1191-1204.
35. Bleyer AJ, Fumo P, Snipes ER et al. Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney Int 1994; 45: 659-666.
36. Tang SC, Chan LY, Leung JC et al. Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant 2010; 25: 698-710.
37. Panchapakesan U, Sumual S, Pollock CA et al. PPAR gamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 2005; 289: F1153-F1158.
38. Lv ZM, Wang Q, Wan Q et al. The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells. PLoS ONE 2011; 6: e22806.
39. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69: 73-80.
40. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNFalpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233.
41. Burns WC, Twigg SM, Forbes JM et al. Connective tissue growth factor plays an important role in advanced glycation end productinduced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17: 2484-2494.
42. Nakagawa T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am J Physiol Renal Physiol 2007; 292: F1665-F1672.
43. Tang SC, Leung JC, Chan LY et al. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator- activated receptor-{gamma} agonist. J Am Soc Nephrol 2006; 17: 1633-1643.
44. Tang SC, Leung JC, Chan LY et al. Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: role of STAT1 inhibition and nephrin restoration. Am J Nephrol 2010; 32: 145-155.
45. Cohen MP, Sharma K, Jin Y et al. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J Clin Invest 1995; 95: 2338-2345.
46. Chung AC, Zhang H, Kong YZ et al. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. J Am Soc Nephrol 2010; 21: 249-260.
47. Masola V, Gambaro G, Tibaldi E et al. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. Biochim Biophys Acta 2011; 1813: 1475-1482.
48. Li JH, Wang W, Huang XR et al. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 2004; 164: 1389-1397.
49. Morcos M, Sayed AA, Bierhaus A et al. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002; 51: 3532-3544.
50. Tang SC, Chan LY, Leung JC et al. Differential effects of advanced glycation end-products on renal tubular cell inflammation. Nephrology (Carlton) 2011; 16: 417-425.
51. D'Agati V, Schmidt AM. RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol 2010; 6: 352-360.
52. Oldfield MD, Bach LA, Forbes JM et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001; 108: 1853-1863.
53. Nosadini R, Tonolo G. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metab Cardiovasc Dis 2011; 21: 79-85.
54. Brezniceanu ML, Liu F, Wei CC et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007; 71: 912-923.
55. Prabhakar S, Starnes J, Shi S et al. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 2007; 18: 2945-2952.
56. Chander PN, Gealekman O, Brodsky SV et al. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004; 15: 2391-2403.
57. Brezniceanu ML, Liu F, Wei CC et al. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008; 57: 451-459.
58. Wolf G, Mueller E, Stahl RA et al. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 1993; 92: 1366-1372.
59. Wolf G, Ziyadeh FN. Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 1997; 17: 448-454.
60. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008; 4: 39-45.
61. Wang SN, Lapag e J, Hirschberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 2000; 57: 1002-1014.
62. Vallon V, Platt KA, Cunard R et al. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol 2011; 22: 104-112.
63. Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 2012; 74: 351-375.
64. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 2003; 14: 530-537.
65. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 2000; 77: S59-S66.
66. Leeb-Lundberg LM, Marceau F, Muller-Esterl Wet al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005; 57: 27-77.
67. Kakoki M, Smithies O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 2009; 75: 1019-1030.
68. Harvey JN, Jaffa AA, Margolius HS et al. Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes 1990; 39: 299-304.
69. Riad A, Zhuo JL, Schultheiss HP et al. The role of the renal kallikrein- kinin system in diabetic nephropathy. Curr Opin Nephrol Hypertens 2007; 16: 22-26.
70. Tang SC, Chan LY, Leung JC et al. Additive renoprotective effects of B2-kinin receptor blocker and PPAR-gamma agonist in uninephrectomized db/db mice. Lab Invest 2011; 91: 1351-1362.
71. Tang SC, Leung JC, Lai KN. The kallikrein-kinin system. Contrib Nephrol 2011; 170: 145-155.
72. Hollenberg MD, Oikonomopoulou K, Hansen KK et al. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol Chem 2008; 389: 643-651.
73. Yiu WH, Leung JC, Chan LY et al. High glucose promotes renal tubular CTGF expression via the activation of protease-activated receptors. J Am Soc Nephrol 2011; 21: 713A. Ref type: Abstract.
74. Dasu MR, Devaraj S, Zhao L et al. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008; 57: 3090-3098.
75. Shi H, Kokoeva MV, Inouye K et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
76. Wolf G, Bohlender J, Bondeva T et al. Angiotensin II upregulates toll-like receptor 4 on mesangial cells. J Am Soc Nephrol 2006; 17: 1585-1593.
77. Giorgini A, Brown HJ, Sacks SH et al. Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells. Am J Pathol 2010; 177: 644-653.
78. Summers SA, van der Veen BS, O'Sullivan KM et al. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 2010; 78: 1263-1274.
79. Wu X, Guo R, Wang Y et al. The role of ICAM-1 in endotoxininduced acute renal failure. Am J Physiol Renal Physiol 2007; 293: F1262-F1271.
80. Reyna SM, Ghosh S, Tantiwong P et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 2008; 57: 2595-2602.
81. Devaraj S, Dasu MR, Park SH et al. Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 2009; 52: 1665-1668.
82. Dasu MR, Devaraj S, Park S et al. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010; 33: 861-868.
83. Nakagawa T, Sato W, Glushakova O et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550.
84. Li F, Yang N, Zhang L et al. Increased expression of toll-like receptor 2 in rat diabetic nephropathy. Am J Nephrol 2010; 32: 179-186.
85. Devaraj S, Tobias P, Kasinath BS et al. Knockout of toll-like receptor- 2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol 2011; 31: 1796-1804